This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Image: Bigstock
2 ETFs to Watch for Outsized Volume on Dividend and Pharma
In the last trading session, Wall Street logged in modest losses as the comeback rally stalled. Among the top ETFs, (SPY - Free Report) lost 0.4% and (DIA - Free Report) shed 0.2%, while (QQQ - Free Report) moved 0.7% lower on the day.
Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most-recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues.
(DIV - Free Report) : Volume 11.51 Times Average
This dividend ETF was in the spotlight as around 2.2 million shares moved hands compared with an average of 222,000 shares a day. We also saw some price movement as DIV gained 1.5% in the last session.
The move was largely the result of volatility and uncertainty that could have a big impact on the dividend stocks like the ones we find in this ETF portfolio. DIV has plunged 3.7% over the past month and carries a Zacks ETF Rank #3 (Hold) with a Medium risk outlook.
(XPH - Free Report) : Volume 6.11 Times Average
This pharma ETF was under the microscope as nearly 387,000 shares moved hands. This compares with an average trading volume of roughly 64,000 shares and came as XPH climbed 3.1% in the last trading session.
The movement can largely be blamed on a defensive tilt given the market turmoil. XPH is up 2.3% in a month’s time and has a Zacks ETF Rank #3 with a High risk outlook.